Published on December 16, 2014

During the month of November, 2014 Gujarat pharma market saw the highest growth rate at 22.4%, beating the industry growth rate. According to the researched report, in the last month the Gujarat pharma industry had grew by 22.4%, which was double the growth rate of the Indian pharmaceuticals market that had grew by 10.9%. However as per the industry experts, the growth rate of the industry in the 14 regions have outgrown as per            a regional perspective and apart from Gujarat that had grew the highest at 22.4%, Chattisgarh and Madhya Pradesh market had also showed a rise of 19.6% and 19.3%, respectively.

Moreover, during this quarter the Indian pharma market (IPM) has overall grown by 12.1% on a year-on-year basis, which is noted higher than the previous quarter as well the corresponding quarter last fiscal.

As per the sources, in the last six months the domestic market after two years slouches have recorded higher volumes and for the quarter ended November, 2014 the volumes grew by 4.6% aligned with a drop of 1.6% in the year-ago epoch. According to the data released by one of the researched report, in compare to the MNCs domestic market counterparts, MNCs have clocked the highest growth and amid the top-ten pharma players, Pfizer, Inc. which is an American multinational pharmaceutical corporation had grew 34% in the month of November, 2014 when the market growth was overall 11%.

On the other hand, GlaxoSmithKline Pharmaceuticals Ltd. in the month of October, 2014 an Indian subsidiary of GlaxoSmithKline plc which is one of the leading researches based pharmaceutical and healthcare companies of the world had noticed the fastest growth at 13%. However as per the market players, in emerging markets (EM) Indian pharma companies with 3-17% of sales amid the weakening currencies are likely to get adversely impacted.